Company / Current Liabilities
Cyclerion Therapeutics, Inc. Current Liabilities History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$900.0K
FY2025
5-year range
$900.0K / $11.1M
FY2021-FY2025
Trend
-56.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $2M to $900,000 over the past 2 years.
Based on SEC 10-K filings.
$900,000 in FY2025 with a 5-year CAGR of -44.4%.
Improved from $2M to $900,000 over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -51.0%
- 5-Year CAGR
- -44.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -44.4%, indicating a declining trend.
- In FY2025, current liabilities decreased 56.9% year-over-year.
- Peak current liabilities was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score -19.82 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $900.0K | -56.9% |
| FY2024 | $2.1M | +0.0% |
| FY2023 | $2.1M | -72.6% |
| FY2022 | $7.6M | -31.2% |
| FY2021 | $11.1M | -34.6% |
| FY2020 | $17.0M | -7.1% |
| FY2019 | $18.2M | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026